Greater systolic blood pressure visit-to-visit variability was associated independently with increased risk of the composite kidney disease end point ( HR per 1-SD increment , 1.08 [ 95 % CI , 1.01-1 .16 ] ; P = 0.02 ) and end-stage renal disease , but not with the cardiovascular outcome .